A trial of memory effects 15 minutes after intranasal insulin in normal controls or patients with mild‐moderate AD dementia or MCI (N = 61) showed improvement in those without the APOE‐4 genotype (Reger et al., 2006). This evidence concerns the gene INS and Alzheimer disease.